Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
CAPS Rating:
The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.
RSS Headlines
Fool UK
Recs
cheap cheap cheap... let's see how it goes